End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24â 45 years of age

Hdl Handle:
http://hdl.handle.net/10675.2/665
Title:
End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24â 45 years of age
Authors:
Castellsague, X; Munoz, N; Pitisuttithum, P; Ferris, Daron G.; Monsonego, J; Ault, Kevin A; Luna, J; Myers, E; Mallary, S; Bautista, O M; Bryan, J; Vuocolo, S; Haupt, Richard M; Saah, A
Abstract:
Background; Methods; Results; Conclusions
Citation:
Br J Cancer. 2011 Jun 28; 105(1):28-37
Issue Date:
28-Jun-2011
URI:
http://hdl.handle.net/10675.2/665
DOI:
10.1038/bjc.2011.185
PubMed ID:
21629249
PubMed Central ID:
PMC3137403
Type:
Article
ISSN:
1532-1827
Appears in Collections:
Department of Family Medicine: Faculty Research and Presentations

Full metadata record

DC FieldValue Language
dc.contributor.authorCastellsague, Xen_US
dc.contributor.authorMunoz, Nen_US
dc.contributor.authorPitisuttithum, Pen_US
dc.contributor.authorFerris, Daron G.en_US
dc.contributor.authorMonsonego, Jen_US
dc.contributor.authorAult, Kevin Aen_US
dc.contributor.authorLuna, Jen_US
dc.contributor.authorMyers, Een_US
dc.contributor.authorMallary, Sen_US
dc.contributor.authorBautista, O Men_US
dc.contributor.authorBryan, Jen_US
dc.contributor.authorVuocolo, Sen_US
dc.contributor.authorHaupt, Richard Men_US
dc.contributor.authorSaah, Aen_US
dc.date.accessioned2012-10-26T16:27:01Z-
dc.date.available2012-10-26T16:27:01Z-
dc.date.issued2011-06-28|en_US
dc.identifier.citationBr J Cancer. 2011 Jun 28; 105(1):28-37en_US
dc.identifier.issn1532-1827en_US
dc.identifier.pmid21629249en_US
dc.identifier.doi10.1038/bjc.2011.185en_US
dc.identifier.urihttp://hdl.handle.net/10675.2/665-
dc.description.abstractBackgrounden_US
dc.description.abstractMethodsen_US
dc.description.abstractResultsen_US
dc.description.abstractConclusionsen_US
dc.rightsCopyright © 2011 Cancer Research UKen_US
dc.subjectClinical Studyen_US
dc.titleEnd-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24â 45 years of ageen_US
dc.typeArticleen_US
dc.identifier.pmcidPMC3137403en_US
dc.contributor.corporatenameDepartment of Family Medicine-
dc.contributor.corporatenameDepartment of Obstetrics and Gynecology-

Related articles on PubMed

All Items in Scholarly Commons are protected by copyright, with all rights reserved, unless otherwise indicated.